Estrogen receptor degradation: a CUE for endocrine resistance? - Wikidata - awgldk - TriplyDB

Estrogen receptor degradation: a CUE for endocrine resistance?

Estrogen receptor degradation: a CUE for endocrine resistance?

http://www.wikidata.org/entity/Q26830072

about

Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas.

P2860

Q35631627-ED91BA83-8795-4F5C-947C-E4B9B4C346F9

P2860

Estrogen receptor degradation: a CUE for endocrine resistance?

http://www.wikidata.org/entity/Q26830072

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Estrogen receptor degradation: a CUE for endocrine resistance?

@ast

Estrogen receptor degradation: a CUE for endocrine resistance?

@en

Estrogen receptor degradation: a CUE for endocrine resistance?

@nl

type

label

Estrogen receptor degradation: a CUE for endocrine resistance?

@ast

Estrogen receptor degradation: a CUE for endocrine resistance?

@en

Estrogen receptor degradation: a CUE for endocrine resistance?

@nl

prefLabel

Estrogen receptor degradation: a CUE for endocrine resistance?

@ast

Estrogen receptor degradation: a CUE for endocrine resistance?

@en

Estrogen receptor degradation: a CUE for endocrine resistance?

@nl

P1433

Q26830072-0571A49B-8CE4-43DB-BAD7-BD98890E4922

P1476

Q26830072-1CF5C212-2918-4B83-A36F-15E747E4C72F

P2093

Q26830072-5B73863E-68A7-4F9C-A3C0-F6A234FDDD7E

P2860

Q26830072-0724C080-1DCD-4A5B-9C4B-3535C547416B

Q26830072-118297FD-F19E-4E56-8141-3DDEB6CA0A7E

Q26830072-24F0F2C0-9B65-40C4-8C36-F5892E4ED4B8

Q26830072-260A7834-6B49-471A-9A7B-7FF28BC015E5

Q26830072-32750D84-89B9-4488-97C3-F8B8FD44C216

Q26830072-34221C14-5283-4D0D-9DD7-3CF8E6C424ED

Q26830072-5E7AC758-09FA-4232-8D70-222492772967

Q26830072-8C8FB770-4480-4760-9699-70D719438077

Q26830072-9B46DAC0-E3F4-4BCE-B600-77FC88940FE3

Q26830072-B63315BB-EE21-4EEA-AE53-9300910E0779

P2888

Q26830072-4DC2BFC8-5FE5-40D0-9EBB-E91A2C2F8AD4

P304

Q26830072-3654E8F0-4090-4ABA-8583-9D6E5D9F30DB

P31

Q26830072-25033452-A3DA-42E3-91E5-F76E30B449ED

Q26830072-F4AC1039-1A48-4E8B-A007-79CF5637D01D

P356

Q26830072-C4B362F9-B368-4944-BFFC-3D6E5AC9EDD4

P407

Q26830072-531FC149-7C5C-4395-AE46-BE6F056917A2

P433

Q26830072-F96C29D4-FD94-442F-A5DD-00961CCBEFFA

P478

Q26830072-13C57404-10EA-4E2F-9624-6CFAFD50F4A7

P577

Q26830072-4B9713D6-E2A8-4390-A745-B2298552AE0D

P5875

Q26830072-04C5C6B7-5069-49B7-A66D-DA6CF2234D47

P6179

Q26830072-96DA9884-FA60-4EC1-926B-7FE2795603FA

P698

Q26830072-9266E383-7F9E-402C-98CA-3CBE855718C5

P921

Q26830072-012D5396-06F3-4CDD-BFB3-D578B54860DE

Q26830072-303ECA6D-11BB-4B91-9A18-D4065E1C3D0A

Q26830072-390A69B2-2004-4450-8073-2443BC6DE383

Q26830072-BEE67A78-F07D-4076-BE4D-A3CC19826DE3

Q26830072-EA2407AD-1B26-4913-9E82-8522F5BABAD7

Q26830072-F472A302-AD87-45B9-987D-F65F510FBA4B

P932

Q26830072-F9F031E3-F415-48C2-9A65-84AA3C5D94C0

P356

P1433

Breast Cancer Research

P1476

Estrogen receptor degradation: a CUE for endocrine resistance?

@en

P2093

Elizabeth A Musgrove

http://www.w3.org/2001/XMLSchema#string

P2860

LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer

The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells

CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasome

FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Ubiquitin-binding domains

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Molecular and cellular determinants of estrogen receptor alpha expression.

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

Biological determinants of endocrine resistance in breast cancer.

P2888

P304

312

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR2914

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51590486

http://www.w3.org/2001/XMLSchema#string

P6179

1040755343

http://www.w3.org/2001/XMLSchema#string

P698

21861853

http://www.w3.org/2001/XMLSchema#string

P921

intracellular receptor

transport protein

membrane proteins

breast neoplasm

physiological phenomena

P932

3236333

http://www.w3.org/2001/XMLSchema#string